The document discusses the management of biomedical waste from hospitals. It notes that hospital waste is classified as 85% non-hazardous and 15% hazardous, with the hazardous waste further divided into infectious (10%) and toxic (5%). The key aspects of management include proper segregation of waste based on category at the point of generation, use of colored containers, treatment and disposal options according to waste type, and compliance with the Bio-Medical Waste (Management and Handling) Rules 1998 which regulate waste disposal. Improper management can pose health risks like infections to patients, staff and the public.
-Bio-Medical Waste
-Contents:
-Evolution of Bio-Medical Waste in India
-Biomedical Waste
-Need of Rules for Bio-Medical Waste
-Present Scenario in India
-Disease Caused by Improper Disposal of Waste
-BMW(H&M) 1998
-Major Differences between BMW 1998 and BMW 2016
-BMW (H&M) 2016
-Conclusion
Evolution of Bio-Medical Waste Management Rules in India:
-First Bio-Medical Rules were notified by the Govt. of India, erstwhile
MOEF on 20th July 1998.
-Modification in the next following years (2000, 2003 and 2011)
-BMW rules 2011 remained as the draft
-MOEFCC in March 2016 has amended the BMWM rules.
-BMW Management 2016 was released on 27 March 2016
Bio-Medical Waste:
means any waste, which is generated during the diagnosis, treatment or immunisation of human beings or animals
or research activities pertaining thereto
or in the production or testing of biological or in health camps, including the categories mentioned in Schedule I appended to these rules;
-Bio-Medical Waste
-Contents:
-Evolution of Bio-Medical Waste in India
-Biomedical Waste
-Need of Rules for Bio-Medical Waste
-Present Scenario in India
-Disease Caused by Improper Disposal of Waste
-BMW(H&M) 1998
-Major Differences between BMW 1998 and BMW 2016
-BMW (H&M) 2016
-Conclusion
Evolution of Bio-Medical Waste Management Rules in India:
-First Bio-Medical Rules were notified by the Govt. of India, erstwhile
MOEF on 20th July 1998.
-Modification in the next following years (2000, 2003 and 2011)
-BMW rules 2011 remained as the draft
-MOEFCC in March 2016 has amended the BMWM rules.
-BMW Management 2016 was released on 27 March 2016
Bio-Medical Waste:
means any waste, which is generated during the diagnosis, treatment or immunisation of human beings or animals
or research activities pertaining thereto
or in the production or testing of biological or in health camps, including the categories mentioned in Schedule I appended to these rules;
The health of patients is important to hospitals making it imperative to properly dispose of biomedical waste. Having the proper biomedical waste containers is part of keeping patients safe from illnesses they could contract while in the hospital.
The health of patients is important to hospitals making it imperative to properly dispose of biomedical waste. Having the proper biomedical waste containers is part of keeping patients safe from illnesses they could contract while in the hospital.
Biomedical waste
‘Bio-medical waste’ means any solid and/or liquid waste including its container and any intermediate product, which is generated during the diagnosis, treatment or immunization of human beings or animals or in research pertaining thereto or in the production or testing thereof.
Biomedical Waste is any kind of waste that contains infectious material (or material that’s potentially infectious). This definition includes waste generated by healthcare facilities like physician’s offices, hospitals, dental practices, laboratories, medical research facilities, and veterinary clinics
THIS presentation EXPLAINS biomedical waste management IN EASY WAY
Important links- NOTES- https://mynursingstudents.blogspot.com/
youtube channel
https://www.youtube.com/c/MYSTUDENTSU...
CHANEL PLAYLIST-
ANATOMY AND PHYSIOLOGY-https://www.youtube.com/playlist?list...
COMMUNITY HEALTH NURSING- https://www.youtube.com/playlist?list...
CHILD HEALTH NURSING- https://www.youtube.com/playlist?list...
FIRST AID- https://www.youtube.com/playlist?list...
HCM- https://www.youtube.com/playlist?list...
FUNDAMENTALS OF NURSING- https://www.youtube.com/playlist?list...
COMMUNICABLE DISEASES- https://www.youtube.com/playlist?list...
ENVIRONMENTAL HEALTH- https://www.youtube.com/playlist?list...
MSN- https://www.youtube.com/playlist?list...
HINDI ONLY- https://www.youtube.com/playlist?list...
ENGLISH ONLY- https://www.youtube.com/playlist?list...
facebook profile- https://www.facebook.com/suresh.kr.lrhs/
FACEBOOK PAGE- https://www.facebook.com/My-Student-S...
facebook group NURSING NOTES- https://www.facebook.com/groups/24139...
FOR MAKING EASY NOTES YOU CAN ALSO VISIT MY BLOG –
BLOGGER- https://mynursingstudents.blogspot.com/
Instagram- https://www.instagram.com/mystudentsu...
Twitter- https://twitter.com/student_system?s=08
#VITAMIN_A,#FUNCTIONS,#SOURCE, #DEFICIENCY,#DISEASE,#NIGHTBLINDNESS#XEROPHTHALMIA,#BITOTSPOT,#CORNEALXEROSIS, #CONJUNCIVALXEROSIS, YELLOWFRUITS,#MYSTUDENTSUPPORTSYSTEM, #rashes,#nursingclasses, #communityhealthnursing,#ANM, #GNM, #BSCNURING,#NURSINGSTUDENTS, #WHO,#NURSINGINSTITUTION,#COLLEGEOFNURSING,#nursingofficer,#COMMUNITYHEALTHOFFICER
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
2. INTRODUCTION
• Hospital wastes always considered potentially
hazardous.
• Wider variety of hazardous materials are
infected material, cytotoxicdrugs corrosive
chemicals and radioactive substances.
• Major hazard is of infection.
• Rising trend of HBV and HIV infection to
community and health provider.
• Safe and sustainable method of disposal of
waste material.
3. NATURE AND QUANTUM OF HOSPITAL WASTE
Three major categories of hospital in India
1. Outpatient clinic or dispensaries
2. Outpatient and inpatient care hospitals
3. Civil hospital Distt. hospital, nursing home,
medical college hospital etc.
4. HOSPITAL WASTE AND TERMINOLOGY
1. Hospital waste - mean bio medical waste
generated from different departments of hospital,
85% wastes non hazardous 10% infectious wastes
5% non - infectious waste.
2. Medical wastes - generated from diagnosis,
treatment or immunization of human being or
animal.
3. clinical wastes - Any wastes coming out of medical
care in hospital or other clinics and dispensaries.
4. Pathological waste - include human tissues,
organs, body parts removed during surgery or
autopsy from medical procedures.
5. Infectious wastes - includes all kind of wastes
which may transmit viral, bacterial or parasitic
diseases also include animal infectious wastes.
7. Non hazardous :- General office wastes –
papers, cartons ,plastic etc.
Kitchen waste
a. Biodegradable - peels of fruit and
vegetable skin and left over food, tea,
drugs and other natural kitchen waste
b. Non Biodegradable – Wrappings, foils,
plastic bags and other material
8.
9. HAZARDOUS
(A) Potentially infectious
1. Dressing & swabs
2. Laboratang wastes
3. Instruments used in patient care
4. Potentially infected materials- placentas, tissues
organs etc.
5. Potentially infected animals
10. (B) Potentially toxic waste
1. Radioactive waste - Solid liquid and gases
used for diagnosis &
treatment
2. Chemical waste - They may be hazardous
toxic corrosive and
inflammable
3. Pharmaceutical waste - Surplus or expiry
date medicines
11.
12. QUANTUM OF WASTES
1-5 Kg./person developed countries
1-2 Kg./person developing countries
13. HEALTH HAZARD WITH POOR HOSPITAL WASTES
MANAGEMENT
1. Injuries from sharp to hospital persons.
2. Nosocomial infection
3. Risk of infection outside hospital to waste handlers and
general public
4. Risk with hazardous chemicals and drugs to waste
handlers
5. Recycling and repacking of Disposable items
6. Infections – Infection disease – HBV, HIV
14. ROUTE OF TRANSMISSION OF INFECTION FROM
INFECTIOUS WASTES THROUGH
1. Non – intact skin.
2. Mucous membrane.
3. Inhalation of dust particles.
4. Ingestion through contaminated food and water and
unwashed hands.
15.
16. CATEGORIES OF PERSONS EXPOSED TO RISK OF
INFECTION
1. Other patients and attainders.
2. Medical / paramedical persons.
3. Persons involved in collection and disposal.
4. Involved in cleaning instruments floor, surfaces
and washing of glass ware and linen.
5. Potential waste mixed with solid waste, entire
chain of persons involved in solid wastes
disposal.
6. Recycled and reused of unsterilised disposal
items.
17. HOSPITAL WASTE MANAGEMENT (FOR
PREVENTION OF HAZARDS)
• Cleanliness and good hygiene.
• Prevention of infection from patient to patient and
patient to other.
• Safe disposal of wastes from point of generation to
disposal place is important.
18. PRINCIPLES OF INFECTION CONTROL
1. Infection control measures
• a.) Infection control policy (ICP).
• b.) Hand washing.
• c.) Disinfections.
1. Patients Admissions.
2. Hygienic environment
3. Monitoring of infectious agents, finding the
source of infection & its preventive measures.
4. Waste reduction- select disposable and
reusable item to reduce waste.
•
19. BIO MEDICAL WASTE (MANAGEMENT & HANDLING )
RULES -1998
Ministry of environment & forest notified a rule
to regulate disposal of biomedical waste
including human anatomical wastes, blood &
body fluids, medicines and glassware’s, solid
liquid and biotechnology waste from occupiers of
clinic, dispensaries, pathology laboratories, blood
bank, providing treatment/services, known as
Biomedical waste (management & Handling)
Rules -1998
20. CATEGORIES OF BIO-MEDICAL WASTES
Category Type of Waste
Treatment &
Disposal Option
Category
1
Human Anatomical Wastes
(Human tissues, organs, body parts)
Incineration/deep
burial
Category
2
Animal wastes
(Animal tissues, organs, body parts,
carcasses, bleeding part, fluid, blend and
experimental animals used in research
waste generated by veterinary hospitals)
Incineration/deep
burial
Category
3
Microbiology and Bio-technology wastes
(wastes from laboratory cultures, stocks or
specimens of micro-organisms, live or
attenuated vaccines, human and animal
cell culture used in research and industrial
laboratories, wastes from biological
productions, toxins, dishes and devices
used to transfer cultures)
Local/Autoclaving
/Micro-waving
/incineration
21. Category Type of Waste
Treatment &
Disposal Option
Category 4
Waste Sharps
(Needles, syringes, scalpels, blades,
glass etc. that are capable of causing
puncture and cuts. this includes both
used and unused sharps)
Disinfection
(Chemical)/
Autoclaving/
Microwaving and
mutilation/Shredding
Category 5
Discarded Medicines and Cytotoxic Drugs
(Waste comprising of outdated,
contaminated and discarded drugs and
medicines)
Incineration
/ Destruction and
disposal in land fills
Category 6
Soiled wastes
(Items contaminated with blood and body
fluids including cotton, dressings, soiled
plaster, linens, bedding, other materials
contaminated with blood)
Incineration/
Autoclaving/
Micro-waving
22. Category Type of Waste
Treatment &
Disposal Option
Category 7
Solid Wastes
(Wastes generated from disposable items
other than the waste sharps such as
tubing, catheters, IV sets, etc.)
Disinfection by
chemical treatment
/Autoclaving and
mutilation/Shredding
Category 8
Liquid wastes
(Liquid wasters- waste generated from
laboratory and washing, cleaning,
home keeping and disinfecting activities
Disinfections by
chemical treatment
and discharge in
to drain
Category 9
Incineration ash
(Ash from incineration of any
Bio-medical wastes)
Disposal in
municipal land fills
Category
10
Chemical Wastes
(Chemicals used in biological production,
chemicals used in disinfection such as
insecticides, etc.
Chemical treatment
and discharge into
drains for liquid and
secured land fills for
solids.
23. Segregation and safe storage
•Segregation at source and safe storage is the
key to hospital waste management.
•Segregation should be carried out at the point of
generation.
•If infectious waste is mixed with other hospital
waste, the entire waste will be treated as
infectious waste.
•Incorrect categorization of waste can lead to
many problems.
24. Advantages of Segregation
•Reduces total treatment cost.
•Reduces impact of this on community.
•Reduces chance of infection among health care
worker.
25. COLOUR CODING AND CONTAINERS FOR DISPOSAL OF
BIO-MEDICAL WASTES
Colour
Coding
Type of
Container
Waste Category Treatment Options
Yello Plastic bags Human & animal wastes, Microbial
and Bio-technological wastes, and
soiled wastes
(Category 1,2,3 and 6)
Incineration/deep
burial
Red Disinfected
container/Plastic
bag
Microbiological and Bio-technological
wastes, soiled wastes, solid waste
(Category-3,6 and 7)
Autoclaving/Microwavi
ng/Chemical treatment
Blue/white
Transpare
nt
Plastic
bag/Puncture
proof container
Waste sharps and solid waste
(Category 4 & 7)
Autoclaving/Microwavi
ng/Chemical treatment,
Destruction and
shredding.
Black Plastic bag Discarded medicines, Cytotoxic drugs,
Incineration Ash and Chemical Wastes
Category 5,8 &9 (Solids)
Disposal in secured
landfills.
28. Day:______ Month _________
Year ______________
Waste Category No. _________ Date of generation__________
Waste Class
Waste Description
Sender's Name & Address Receiver's Name & Address
Phone No.:_________________ Phone No.:_______________
Telex No. _________________ Telex No. :_______________
Fax No. ___________________ Fax No. :________________
Contact Person _____________ Contact Person:____________
In case of emergency please Contact:
Name & Address:
Phone No.
LABEL FOR TRANSPORT OF BIO-MEDICAL WASTE CONTAINERS/BAGS
29. NOTE:-
1.No BMW shall be kept stored beyond a period of
48 hrs.
2.Categories 8and 10 (liquids) stored in separate
container and disposed in sever line after chemical
treatment.
3. category 3 if disinfected locally need not to be
put in container/bags.